May 4 (Sunday)
MP04-Meet the Professors (Colon Cancer)
Room 102, 1F
Moderator: Kun-Huei Yeh (National Taiwan University Hospital, Taiwan)
7:30-8:20
MP-04
Edward Chu (University of Pittsburgh Cancer Institute, USA)
KS04-Keynote Speech
Plenary Hall, 3-4F
Moderator: Li-Tzong Chen (National Health Research Institutes, Taiwan)
Maximising Survival in Patients Presenting with Unresectable Metastatic
8:30-9:10
KS-04
Colorectal Cancer
Aimery de Gramont (Hôpital Saint-Antoine, GERCOR, France)
CC01-Colon Cancer
Plenary Hall, 3-4F
Moderator: Jin-Tung Liang (National Taiwan University Hospital, Taiwan)
9:30-9:35
Opening Remark
Pretreatment Selection of Regimen According to UGT1A1 Genetic
9:35-10:20
CC01-01
Analysis Improves the Efficacy of Chemotherapy Plus Target Therapy as
First-line Treatment in mCRC
David Paez Lopez-Bravo (Hospital de la Santa CREU I Sant Pau, Spain)
Moderator: King-Jen Chang (Cheng Ching Hospital, Taiwan)
10:20-11:10
CC01-02
Perspectives in MDT Management of mCRC
Wolf Otto Bechstein (Johann Wolfgang Goethe-University, Germany)
Moderator: Jeng-Chang Lee (National Cheng Kung University Hospital, Taiwan)
11:10-12:05
CC01-03
Optimal Treatment Sequence for Unresectable Patients in mCRC
Axel Grothey (Mayo Clinic, USA)
12:05-12:10 Closing Remark
TSC-Taiwan Society of Coloproctology
12:30-13:30
CC02-Colon Cancer
Plenary Hall, 3-4F
Taiwan Society of Coloproctology Voting Session
Room 201-ABC, 2F
Moderators: Jinn-Shiun Chen (Chang Gung Memorial Hospital, Taiwan)
Kun-Huei Yeh (National Taiwan University Hospital, Taiwan)
14:00-14:30
CC02-01
S-1 in the Management of mCRC
Young Suk Park (Samsung Medical Center, Korea)
New Drug Development for Refractory Metastatic Colorectal Cancer in
14:30-15:00
CC02-02 Japan
Takayuki Yoshino (National Cancer Center Hospital East, Japan)
15:00-15:30
CC02-03
New Agents in the Treatment of Colorectal Cancer
Edward Chu (University of Pittsburgh Cancer Institute, USA)
Moderators: Wei-Shou Hwang (Chung Shan Medical University, Taiwan)
Jaw-Yuan Wang (Kaohsiung Medical University hospital, Taiwan)
Biomarkers in Colorectal Cancers: From Basic Research to Clinical
15:50-16:20
CC02-04 Implication
Jaw-Yuan Wang (Kaohsiung Medical University, Taiwan)
16:20-16:50
CC02-05
Yttrium-90 Microspheres for Liver Metastasis from Colorectal Cancer
Yee Chao (Taipei Veterans general Hospital, Taiwan)
GI03-Gastrointestinal Tract (non-Colon) Cancer
Room 201-ABC, 2F
Moderators: Yi-Yen Jan (Chang Gung Memorial Hospital, Taiwan)
Prasit Watanapa (Mahidol University, Thailand)
Epidemiologic Analysis of Bile Duct Cancer in Taiwan--Report from A
9:30-9:55
GI03-01 Tertiary Referral Surgical Center
Ta-Sen Yeh (LinKou Chang Gung Memorial Hospital, Taiwan)
9:55-10:25
GI03-02
10:25-10:55
GI03-03
10:55-11:20
GI03-04
Bile Duct Cancer in Asia
Prasit Watanapa (Mahidol University, Thailand)
Adjuvant Therapy for Bile Duct Cancer
Itaru Endo (Yokohama City University, Japan)
Update Medical Treatment for Advanced Biliary Tract Cancer
Li-Tzong Chen (National Health Research Institutes, Taiwan)
LU02-Lung Cancer
9:10-9:20
Opening Remark
Reury-Perng Perng (Taipei Veterans general Hospital, Taiwan)
Moderator: Teh-Ying Chou (Taipei Veterans General Hospital, Taiwan)
Room 102, 1F
Stratifin and ECT2 are Associated with Tissue Carcinogenesis and Early
9:20-10:00
LU02-01 Malignant Progression of Lung Adenocarcinoma
Masayuki Noguchi (University of Tsukuba, Thailand)
Moderator: Wen-Hu Hsu (Taipei Veterans General Hospital, Taiwan)
Optimal Surgical Approach for Lung Cancer Less Than 2 cm. Stratification
10:00-10:40
LU02-02 by Histology
Scott J. Swanson (Brigham and Women’s Hospital, USA)
Moderator:
10:40-11:20
Jacqueline Whang-Peng (Taipei Medical University-Wan Fang Hospital, Taiwan)
LU02-03
Role of Chemotherapy in Era of Driver Oncogene Inhibition Therapy
Yuh-Min Chen (Taipei Veterans General Hospital, Taiwan)
Moderator: Nan-Yung Hsu (Taipei Medical University, Taiwan)
11:20-12:00
LU02-04
Effect of HPV in Chemotherapy Response of Lung Cancer
Ya-Wen Cheng (Taipei Medical University, Taiwan)
TLCS-Taiwan Lung Cancer Society
12:00-12:20
Room 102, 1F
Taiwan Lung Cancer Society Assembly
Proposal of Consensus Statement for Low-dose CT Lung Cancer Screening in Taiwan
AL-COS-Chien-Tien Hsu’s Award and Ta-Cheng Tung’s Award
Room 402, 4F
Long-Hsiung Hsu (Chien-Tien Hsu Cancer Research Foundation, Taiwan)
Moderators: Tsang-Wu Liu (National Health Research Institutes, Taiwan)
Tsu-Yi Chao (Taipei Medical University Shuang Ho Hospital, Taiwan)
Translational study of Nanotechnology on the Treatment of Malignant
9:30-10:20
AL-COS-01 Brain Tumor
Kuo-Chen Wei (Chang Gung Memorial Hospital, Taipei, Taiwan)
Kwang-Shih Tung (Traditional Chinese medicine Research Foundation, Taiwan)
Moderators:
Ching-Hua Su (Traditional Chinese medicine Research Foundation, Taiwan)
Tsang-Wu Liu (National Health Research Institutes, Taiwan)
Chin-Wen Chi (National Yang-Ming University, Taiwan)
Investigation of Stemness Signature and Tumor-initiating Property in
10:30-11:20
AL-COS-02 Malignant Cancers
Shih-Hwa Chiou (National Yang-Ming University, Taiwan)
COS-The Chinese Oncology Society
Room 402, 4F
11:30-12:20 The Chinese Oncology Society Assembly
GU01-Genitourinary
Room 103, 1F
Moderators: Hideyuki Akaza (The University of Tokyo, Japan)
Thomas IS Hwang (Shin Kong Wu Ho-Su Memorial Hospital, Taiwan)
9:30-10:10
GU01-01
Renal Cell Carcinoma in 2014: A Rapidly Evolving Field
Sumanta Kumar Pal (City of Hope Comprehensive Cancer Center, USA)
OP04-Oral Presentation (Genitourinary Cancer)
Room 103, 1F
Moderators: Yeong-Shiau Pu (National Taiwan University Hospital, Taiwan)
Wen-Jeng Wu (Kaohsiung Medical University Chung-Ho Memorial Hospital, Taiwan)
The Prognostic Significance of Lymphovascular Invasion in Upper Urinary
10:10-10:25
OP04-01 Tract Urothelial Carcinoma is Influenced by Tumor Location
Hsin-Chih Yeh (Kaohsiung Medical University Hospital, Taiwan)
Double-Barreled Rifle Colostomy for Simultaneous Urinary and Fecal
10:25-10:40
OP04-02 Diversions
Lin-Nei Hsu (Kaohsiung Chang Gung Memorial Hospital, Taiwan)
The 4-Year Result of Stereotactic Body Radiotherapy for Localized Prostate
10:40-10:55
OP04-03 Cancer
Yu-Wei Lin (Chi Mei Medical Center, Taiwan)
Does the Resection Depth of Turbt Effects Superficial Bladder Tumor
10:55-11:10
OP04-04 Recurrence?
Kuan-Hsin Huang (National Cheng-Kung University Hospital, Taiwan)
GU02-Genitourinary
Room 103, 1F
Moderators: Kuang-Kuo Chen (Taipei Veterans general Hospital, Taiwan)
Sang-Hue Yen (Taipei Veterans General Hospital, Taiwan)
14:00-14:30 GU02-01
14:30-15:10 GU02-02
Recent Advances in Management of Castration-refractory Prostate Cancer
Shauh-Der Yeh (Taipei Medical University Hospital, Taiwan)
Heavy Ion Radiotherapy in Prostate Cancer
Kazuhiro Suzuki (Gunma University Graduate School of Medicine, Japan)
Moderators: Dah-Shyong Yu (Tri-Service General Hospital, Taiwan)
Cheng-Keng Chuang (Chang Gung Memorial Hospital, Taiwan)
15:30-16:10 GU02-03 How to Improve Erectile Function after Prostate Cancer Treatment
Sae Woong Kim (The Catholic University of Korea, Korea)
Single-use, Disposable Platform Biosensors for the Detection of
16:10-16:50 GU02-04
Alpha-methylacyl-coa Racemase (AMACR), A Biomarker of Prostate
Cancers
Chung Chiun Liu (Case Western Reserve University, USA)
HM01-Hematology
Room 201-DEF, 2F
Moderator: Hwei-Fang Tien (National Taiwan University Hospital, Taiwan)
9:30-10:10
HM01-01
Molecular Profiling of MDS
Seishi Ogawa (Kyoto University, Japan)
Mutations of RNA Splicing Machinery Genes: The Clinical Implications in
10:10-10:35 HM01-02 Myelodysplastic Syndrome
Shang-Ju Wu (National Taiwan University Hospital, Taiwan)
Moderator: Lee-Yung Shih (Chang Gung Memorial Hospital, Taiwan)
10:50-11:30 HM01-03
Genetics Guided Therapeutic Approaches in AML
Lars Bullinger (University Hospital of Ulm, Germany)
Genetic Alterations of AML in Taiwan: Prognostic and Therapeutic
11:3011:55
HM01-04 Implications
Hsin-An Hou (National Taiwan University Hospital, Taiwan)
11:55-12:20 HM01-05
Challenges in the Treatment of Elderly Acute Myeloid Leukaemia
Yok-Lam Kwong (Queen Mary Hospital, Hong Kong, China)
HM02-Hematology
Room 201-DEF, 2F
Moderator: Tzeon-Jye Chiou (Taipei Veterans general Hospital, Taiwan)
14:00-14:40 HM02-01
14:40-15:10 HM02-02
BCR Signaling as the Target for the Treatment of B-lymphoid Malignancies
Adrian Wiestner (National Heart, Lung, and Blood Institute, USA)
Novel Therapeutic Targets in T-cell Lymphoma - Are We There Yet?
Kevin Tay (National Cancer Center Singapore, Singapore)
Helicobacter pylori-related Gastric Lymphoma: New Insights on Biology
15:10-15:40 HM02-03 and Treatment
Sung-Hsin Kuo (National Taiwan University Hospital, Taiwan)
Moderator: Sheng-Fung Lin (Kaohsiung Municipal Ta-Tung Hospital, Taiwan)
15:55-16:25 HM02-04
Impact of Molecular Alterations on Myeloma Treatment
Wee-Joo Chng (National University Cancer Institute of Singapore,
Singapore)
Cereblon: A Potential Biomarker to Predict the Treatment Response of
16:25-16:55 HM02-05 Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Shang-Yi Huang (National Taiwan University Hospital, Taiwan)
BC03-Breast Cancer
Banquet Hall, 3F
Moderators: Shih-Hsin Tu (Cathay General Hospital, Taiwan)
Hsien-Kun Chang (Chang Gung Medical Foundation, Taiwan)
The Clinical Practice of Eribulin for Metastatic Breast Cancer -- The
7:35-8:05
BC03-01 Experience Sharing and the Perspective
Keun Seok Lee (National Cancer Center, Korea)
8:05-8:50
BC03-02
Current Treatment Options for Advanced Triple Negative Breast Cancer
Joyce O'Shaughnessy (Baylor-Sammons Cancer Center, USA)
Moderators: San-Kan Lee (Taichung Veterans General Hospital, Taiwan)
Dar-Ren Chen (Changhua Christian Hospital, Taiwan)
9:00-9:25
BC03-03
9:25-9:40
BC03-04
9:40-10:05
BC03-05
Guideline for Breast Elastography in Japan
Kazutaka Nakashima (Kawasaki Medical School, Japan)
3-D Elastography
Etsuo Takada (Nasu Red Cross Hospital, Japan)
Contrast Enhanced Ultrasonography
Toshikazu Ito (Rinku General Medical Center, Japan)
Moderators: Tsen-Long Yang (Shin Kong Wu Ho-Su Memorial Hospital, Taiwan)
Tsai-Wang Chang (National Cheng Kung University Hospital, Taiwan)
Randomized Controlled Trial to Verify the Efficacy of Ultrasonography for
10:40-10:55
BC03-06 Breast Cancer Screening: Up-dated Data from the J-START
Akihiko Suzuki (Tohoku University, Japan)
Standadized Terms in Breast Ultrasound
10:55-11:10
BC03-07 Hidemitsu Yasuda (National Center for Global Health and Medicine,
Japan)
Genetic counseling of HBOC in Japan
11:10-11:30
BC03-08 Seigo Nakamura / Junko Yotsumoto (Showa University School Of
Medicine, Japan)
11:30-11:50
BC03-09
Prophylactic Mastectomy
Hideko Yamauchi (St. Luke’S International Hospital, Japan)
11:50-12:05 Panel Discussion
BC04-Breast Cancer
Banquet Hall, 3F
Moderators: Shyr-Ming Sheen-Chen (Kaohsiung Chang Gung Memorial Hospital, Taiwan)
Hong-Tai Chang (Kaohsiung Veterans General Hospital, Taiwan)
Choice of Nipple Sparing Mastectomy Rather Than Oncoplastic Surgery
14:00-14:25
BC04-01 for Large Operable Breast Cancer in CGMH
Shin-Cheh Chen (Chang Gung Memorial Hospital, Taiwan)
Endoscopic Assisted Breast Surgery in the Management of Breast
14:25-14:45
BC04-02 Cancer-An Overview of Current Evidence
Hung-Wen Lai (Changhua Christian Hospital, Taiwan)
The Learning Curve of Endoscopic Mastectomy. How Many Cases Should
14:45-14:55
BC04-03 be Practiced
Chin-Sheng Hung (Taipei Medical University, Taiwan)
14:55-15:15
15:15-15:30
BC04-04
Breast Cancer Surgery: Intercourse between General and Plastic Surgeons
Yao-Lung Kuo (National Cheng Kung University, Taiwan)
Panel discussion
Koichiro Tsugawa (St. Marianna University School of Medicine, Japan)
Moderators: Tse-Jia Liu (Wanfang Hospital, Taiwan)
Fiona Tsui-Fen Cheng (Shin Kong Wu Ho-Su Memorial Hospital, Taiwan)
Do We Meet the Need of Breast Cancer Survivors? - Post-lumpectomy
15:50-16:05
BC04-05 Breast Deformity and Impact on Quality of Life
Chia-Ming Hsieh (Taiwan Adventist Hospital, Taiwan)
16:05-16:25
BC04-06
16:25-16:40
BC04-07
16:40-16:55
Oncoplastic Technique for Upper / Upper Inner Quadrant Breast Cancer
Dar-Ren Chen (Changhua Christian Hospital, Taiwan)
Who Should Not Have Oncoplastic Breast Surgery?
Ming-Hsin Yeh (China Medical University Hospital, Taiwan)
Panel discussion
Hideko Yamauchi (St. Luke’S International Hospital, Japan)
HN01-Head and Neck Cancer
Opening Remark
9:00-9:20
Mu-Kuan Chen (Changhua Christian Hospital, Taiwan)
Sen-Tien Tsai (National Cheng Kung University Hospital, Taiwan)
Sheng Po Hao (Shin Kong Wu Ho-Su Memorial Hospital, Taiwan)
Moderators: Sen-Tien Tsai (National Cheng Kung University Hospital, Taiwan)
VIP Room, 4F
Chih-Yen Chien (Kaohsiung Chang Gung Memorial Hospital, Taiwan)
9:20-10:00
HN01-01
Shifting Paradigms of Oral Cancers
AK D'Cruz (Taka Memorial Hospital, India)
Moderators: Sheng-Po Hao (Shin Kong Wu Ho-Su Memorial Hospital, Taiwan)
Ming-Hsui Tsai (China Medical University Hospital, Taiwan)
Sinonasal and Skull Base Cancer: Progress, Challenges, and Future
10:00-10:50 HN01-02
Directions
Ehab Y. Hanna (The University of Texas MD Anderson Cancer Center,
USA)
Moderators: Chun-Hung Hua (China Medical University Hospital, Taiwan)
Chen-Chi Wang (Taichung Veterans General Hospital, Taiwan)
Robotic Surgery for Otolaryngology and Head Neck Surgery: Progress,
11:10-11:50 HN01-03 Challenge, and Strategy
Tsung-Lin Yang (National Taiwan University Hospital, Taiwan)
Moderator:
Pei-Jen Lou (National Taiwan University Hospital, Taiwan)
Treatment Modalities for Head and Neck Cancers in Advanced
11:50-12:20
MP-06
Locoregional Stages
Chun-Hung Hua (China Medical University Hospital, Taiwan)
Chia-Jui Yen (National Cheng Kung University Hospital, Taiwan)
HN02-Head and Neck Cancer
VIP Room, 4F
Moderators: Feng-Yu Chiang (Kaohsiung Medical University Hospital, Taiwan)
Ku-Hao Fang (Linkou Chang Gung Memorial Hospital, Taiwan)
14:00-14:30 HN02-01
Moderators:
Kwang-Yoon Jung (Korea University Hospital, Korea)
Yaoh-Shiang Lin (Tri-Service General Hospital, Taiwan)
Jih-Chuan Jan (China Medical University Hospital, Taiwan)
14:30-15:00 HN02-02
Moderators:
Recent Change of Thyroid Surgery in Korea
Transoral Laser Microsurgery for Laryngeal Cancer
Kang Dae Lee (Kosin University Gospel Hospital, Korea)
Peir-Rong Chen (Hualien Tzu Chi Hospital, Taiwan)
Fu-Min Fang (Kaohsiung Chang Gung Memorial Hospital, Taiwan)
A Comprehensive Study of Plasma Epstein-Barr Virus DNA in
15:20-15:45 HN02-03 Nasopharyngeal Carcinoma
Jin-Ching Lin (Taichung Veterans General Hospital, Taiwan)
Moderators:
Shyh-Kuan Tai (Taipei Veterans General Hospital, Taiwan)
Tzer-Zen Hwang (E-Da Hospital, Taiwan)
Transoral Laser Microsurgery for the Treatment of Moderately Advanced
15:45-16:10 HN02-04 Laryngeal and Hypopharyngeal Cancers
Pen-Yuan Chu (Taipei Veterans General Hospital, Taiwan)
Moderators:
Yi-Shing Leu (Taipei Mackay Memorial Hospital, Taiwan)
Jenn-Ren Hsiao (National Cheng Kung University Hospital, Taiwan)
Lifetime Risk of Distinct Upper Aerodigestive Tract Cancers and
16:10-16:35 HN02-05 Consumption of Alcohol, Betel and Cigarette
Pei-Jen Lou (National Taiwan University Hospital, Taiwan)
16:35-16:50 Taiwan Head and Neck Society Assembly
Closing Ceremony
16:50-17:00 Ming-Hsui Tsai (China Medical University Hospital, Taiwan)
Mu-Kuan Chen (Changhua Christian Hospital, Taiwan)
SS08-Satellite Symposium--GSK (GU RCC)
Room 103, 1F
Moderator: John Wen-Cheng Chang (Linkou Chang Gung Memorial Hospital, Taiwan)
(RCC) First-line Metastatic Renal Cell Carcinoma: From Research to Real
11:20-12:20
SS08-01
World Robert Coleman “RANK Ligand Inhibition: From Bench to Bedside”
(Breast)
Bernard Escudier (Institut Gustave Roussy, France)
SS09-Satellite Symposium--Bayer (mCRC)
South Lounge, 3F
Moderator: Kuen-Huei Yeh (National Taiwan University Hospital, Taiwan)
Novel Multi-Kinase Inhibitor-A New Hope for Patients with Metastatic
10:20-11:20
SS09-01
Colorectal Cancer
Jayesh Desai (Royal Melbourne Hospital and the Peter MacCallum Cancer
Centre, Australia)
LS06-Luncheon Symposium--Astra Zeneca (Lung Cancer)
Room 103, 1F
Moderator: Chong-Jen Yu (National Taiwan University Hospital, Taiwan)
12:30-13:30
LS06-01
Current and Future Perspective
of Personalized Treatment in
NSCLC: Focus on EGFR
Mutations
Terufumi Kato (Kanagawa
Cardiovascular and Respiratory
Center, Japan)
LS07-Luncheon Symposium--Roche (CRC)
Room 201-ABC, 2F
Moderator: Chen-Yang Shen (Academia Sinica, Taiwan)
From Basic Research to Clinical Implementation-bevacizumab with
12:30-13:30
LS07-01
Potential Predictive Biomarker
Jaw-Yuan Wang (Kaohsiung Medical University Chung-Ho Memorial
Hospital, Taiwan)
LS08-Luncheon Symposium--Novartis (Lung Cancer)
Room 201-DEF, 2F
Moderator:
Lung: ALK Inhibitors for Lung Cancer Treatment
12:30-13:30
LS08-01 Alice Shaw (Massachusetts General Hospital and Harvard Medical School,
USA)
LS09-Luncheon Symposium--Roche (Lung Cancer)
Banquet Hall, 3F
Moderator: Yuh-Min Chen (Taipei Veterans General Hospital, Taiwan)
12:30-13:30
LS09-01
EGFR-TKI in Lung Adeno-carcinoma Management
Gee-Chen Chang (Taichung Veterans General Hospital, Taiwan)
LS10-Luncheon Symposium--Celgene (Pancreas Cancer)
South Lounge, 3F
Moderator: Yee Chao (Taipei Veterans general Hospital, Taipei)
Optimize the Treatment of Metastatic Pancreatic Cancer in Asian Patients:
12:30-13:30
LS10-01 Insights from New Breakthroughs
Li-Wei Wang (Shanghai First People’s Hospital, China)
LS11-Luncheon Symposium--GSK (Breast Cancer)
Moderator: Tsu-Yi Chao (Taipei Medical University Shuang Ho Hospital, Taiwan)
VIP Room, 4F
12:30-13:30
LS11-01
RANK Ligand Inhibition: From Bench to Bedside
Eva González-Suárez (Bellvitge Institute for Biomedical Research, Spain)
LS12-Luncheon Symposium--Takeda (Hematology)
Room 402, 4F
Moderator: Hwei-Fang Tien (National Taiwan University Hospital, Taiwan)
Changing the Paradigm-Clinical Data and Development: CD30 and
12:35-13:05
LS12-01 Brentuximab Vedotin
Anna Sureda (University of Cambridge, UK)
Treatment Paradigm in South Korea-How I Treat
13:0513:20
LS12-02 Dok Hyun Yoon (Asan Medical Center University of Ulsan College of
Medicine, Korea)
AL-KFA-Kobayashi Foundation Award
Room 102, 1F
Opening Remarks
Tsang-Wu Liu (National Health Research Institutes, Taiwan)
Selection Process and Introduction of Winners
Hideyuki Akaza (Kobayashi Foundation for Cancer Research, Japan)
Award Presentation
Tadao Kakizoe (Kobayashi Foundation for Cancer Research, Japan)
Moderators: Jang Yang Chang (National Cheng Kung University, Taiwan)
14:00-15:30
AL-KFA-01
T Cell Lymphoma: Efforts from the Singapore Lymphoma Study Group
Soon Thye Lim (National Cancer Centre Singapore, Singapore)
Moderators: Shigetoyo SAJI (Gifu University, Japan)
Clinical trial-guiding treatment strategies for pancreatic
AL-KFA-02 adenocarcinoma in Taiwan
Li-Tzong Chen (National Health Research Institutes, Taiwan)
KFA Future Plans
Tadao Kakizoe (Kobayashi Foundation for Cancer Research, Japan)
Closing Remarks
Jacqueline Whang-Peng (Taipei Medical University-Wan Fang Hospital, Taiwan)
OP05-Oral Presentation (TJCC-Clinical Research)
14:00-16:50
OP-05
Oral Presentation TJCC-Clinical Research
South Lounge, 3F
OP06-Oral Presentation (TJCC-Basic & Translational Research)
14:00-16:50
OP-06
Oral Presentation TJCC-Basic & Translational Research
Room 402, 4F